The Claim

Rosiglitazone restores insulin-mediated suppression of lipolysis in insulin-resistant adipocytes.

Source: 1093-OR: Metabolite-Driven Reversal of Adipocyte Insulin Resistance Identified by Reliance, a Novel Live Lipolysis Screening Platform

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
44score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In fat cells that are resistant to insulin, rosiglitazone restores the ability of insulin to stop the breakdown of fat.

See the scientific wording

In insulin-resistant adipocytes, rosiglitazone restores insulin-mediated suppression of lipolysis, serving as a positive control in the RELIANCE screening platform.

Why this might work

Rosiglitazone improves how fat cells respond to insulin, which turns off the enzyme that breaks down fat, causing less fat to be released.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: 1093-OR: Metabolite-Driven Reversal of Adipocyte Insulin Resistance Identified by Reliance, a Novel Live Lipolysis Screening Platform

    Scientists used a new tool to test how well insulin stops fat breakdown in fat cells that don’t respond to insulin. They gave rosiglitazone, a known medicine that helps insulin work better, and it worked perfectly — proving the tool works as it should.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.